바로가기메뉴

본문 바로가기 주메뉴 바로가기

logo

  • KOREAN
  • P-ISSN2951-0333
  • E-ISSN2951-0597

Instruction for Authors

 Instructions for Authors

(Submission Guidelines/Formats)

 

 First issued date February 10, 2022

 Revision as of October 6, 2023

Revision as of May 3, 2024

Revision as of December 20, 2024

Revision as of April 20, 2025

 

1. Manuscript Types and Specifications

The Archives of Obesity and Metabolism (AOM) is a peer-reviewed journal published twice per year on June 30 and December 31. This journal covers articles on obesity, metabolic syndrome, and complications of obesity. Manuscripts may include reviews, original research, case reports, perspectives, editorials, and correspondences.

The submission guidelines for the AOM are based on the "Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals" by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/icmje-recommendations.pdf).

Authors must specify the manuscript type on the cover page of their submission.

1) Review: A manuscript presenting insights and perspectives on topics related to obesity, metabolic syndrome, and complications of obesity through a review of existing research. Submissions can be made by the author, or the Editorial Board may request specific topics and contributors.

2) Original Article: A manuscript presenting research findings derived from various studies related to obesity, metabolic syndrome, and complications of obesity.

3) Case Report: A manuscript reporting new or previously unobserved phenomena, as well as clinical cases that are relevant to the scope of the journal and have educational value.

4) Perspective: A manuscript presenting the author’s knowledge and viewpoint on existing or emerging academic issues. Submissions can be made by the author, or the Editorial Board may request specific topics and contributors.

5) Editorial: A manuscript providing commentary and analysis on recently published papers in the AOM. These articles are written by the Editorial Board or authors commissioned by the Editorial Board.

6) Correspondence: A manuscript commenting on recent papers published in the AOM, new cases, or other topics of interest within the scope of the journal.

The final decision on manuscript acceptance is made following the review by the Editorial Board if deemed significant.

2. Preparation of Submitted Manuscripts.

1) Adherence to Reporting Guidelines
The journal recommends that authors identify the essential information required for research based on the study design and incorporate it into the manuscript. The CONSORT guidelines (http://www.consort-statement.org) should be followed for randomized controlled trials, the STROBE guidelines (http://www.strobe-statement.org)for observational studies, the PRISMA guidelines (http://www.prisma-statement.org) for systematic reviews and meta-analyses, and the STARD guidelines (http://www.stard-statement.org)for diagnostic accuracy studies.

For human research, the manuscript should include approval from the Institutional Review Board (IRB). In research utilizing human-derived materials, authors must explicitly state that written informed consent was obtained from all participants prior to inclusion in the study. All procedures involving the use of experimental animals must adhere to the ethical guidelines established by the Institutional Animal Care and Use Committee (IACUC). Authors must indicate that the study protocol was approved by the IACUC (or an equivalent institutional ethics committee), or that all animal procedures conformed to the ethical standards of the institution and complied with the NIH Guide for the Care and Use of Laboratory Animals (http://www.nap.edu/read/5140/chapter/1).

In addition, all manuscripts submitted to this journal must comply with the guidelines recommended by the Gender Innovation Policy (http://gister.re.kr/gis/kr/gender/gender02.php). Authors should distinguish between sex (biological factors) and gender (identity, psychosocial, or cultural factors) when presenting research findings. Ideally, studies should include both male and female participants and perform a comparative analysis of the results. In cases where only one sex is studied, authors are encouraged to provide a rational explanation. The manuscript should also distinguish between race and ethnicity and describe the methods used to determine these categories and their relevance.

2) Guidelines on the Use of Artificial Intelligence (AI)

Archives of Obesity and Metabolism adheres to the guidelines of the International Committee of Medical Journal Editors (ICMJE) and encourages transparent disclosure and responsible use of artificial intelligence (AI) technologies during manuscript preparation.

Generative AI tools may be used in a limited capacity to enhance linguistic clarity, such as grammar correction, vocabulary refinement, and improvement of readability. However, AI must not be used to generate scientific content, interpret data, or draw key research conclusions. If AI tools are used to generate content, create images, write code, process data, or perform translations, such usage must be clearly disclosed at the time of submission. Authors are required to specify the purpose and extent of AI use as outlined below.

(1)  Authorship

AI tools (e.g., chatbots) cannot be credited as authors and must not be listed as co-authors.

 

(2)  Plagiarism and Accountability

All analyses, interpretations, and conclusions must be the intellectual work of the authors. The use of AI-generated text or images that constitutes plagiarism is strictly prohibited. Authors must be aware of the risks associated with inappropriate AI use, including unintentional plagiarism, factual inaccuracies, and hallucinations, and are strongly encouraged to conduct plagiarism and similarity checks prior to submission.

(3)  Citation of AI-Generated Content

Content generated by AI cannot be cited as a primary source.

(4)  Disclosure of AI Use

If AI tools are used in manuscript preparation, the tool’s name, version, and purpose of use must be clearly disclosed in a dedicated section titled "Declaration of Generative AI and AI-Based Tool Use", placed immediately before the References section. Authors may use the following template:

   Declaration of Generative AI and AI-Based Tool Use

 "During the preparation of this manuscript, the authors used [Tool Name] (version [Version]) to assist with [e.g., grammar correction, vocabulary enhancement, or readability improvement]. The authors have thoroughly reviewed the content generated by the AI tool and take full responsibility for the final version of the manuscript."

2) Manuscript Format
The manuscript should be written in Microsoft Word and submitted in A4 size (212×297 mm) with 25.4 mm margins on all sides. The font size should be 10 points, and the text should be written in two columns and have double spacing (2-line spacing). The fonts to be used are Batang or Times New Roman. The line spacing should be two points throughout the cover page, abstract, body, acknowledgments, references, tables, and figures. Page numbers should be placed at the bottom center, starting from the English abstract. Line numbers should be included, starting from the manuscript body.

3) Language and Terminology
The manuscript should be written in Korean, with the abstract in English. The manuscript should adhere to correct spelling and spacing. Academic terms should follow the official medical terminology guide by the Korean Medical Association (http://term.kma.org).

4) Proper Nouns, Drug Names, Numbers, and Units of Measurement
Medical terms that are difficult to translate, proper nouns, drug names, and names of people and places should be written in their original form. In cases where required, Chinese characters may be included in parentheses. Drug names should be written in generic form, except for studies on specific products, in which case, the brand name can be used. Numbers should be expressed in Arabic numerals. Units of measurement such as length, height, mass, and volume should be expressed in metric units (meter, kilogram, liter, etc.), using multiples of 10. The temperature should be in Celsius and blood pressure in mmHg. Hematological values and clinical test results should use the International System of Units (SI).

5) Use of Abbreviations
The use of abbreviations should be kept to a minimum, and only standardized abbreviations should be used. Avoid using abbreviations in titles or abstracts. Unless referring to measurement units, abbreviations should be spelled out the first time they appear in the manuscript, after which the abbreviation can be used throughout the text.

6) Manuscript Preparation
Author names and affiliations, including ORCID, should only appear on the cover page. They should not be included in the main text or any other part of the manuscript.

(1) Review Article
The manuscript should be prepared in the following order:

Cover page (including ORCID), English abstract and keywords, Main body (Introduction, Methods, Results, Conclusion), Conflicts of interest, Funding sources, Acknowledgments (if applicable,), References, Tables (if applicable,), Figures and figure legends (if applicable,), Appendices (if applicable,)

The manuscript length, excluding the cover page, references, English abstract, tables, figures, and figure legends, should not exceed 10,000 words (including spaces). The total number of tables and figures (including photographs) should not exceed 10 and the number of references should be limited to 100.

Cover Page

 The cover page should include the title of the manuscript, running title, and names and affiliations of all authors in both Korean and English. When there are two or more authors, they should be listed in the order of their contributions to the research and manuscript writing, separated by commas. In English, the authors' names should follow the format of first name followed by last name, with the first letter of each syllable capitalized if the name is split. If the authors have different affiliations, Arabic numerals in superscript should be placed after the authors' names and before the institutional names to match the order of authorship. The corresponding author, responsible for revising the manuscript, should have their name, English affiliation, address, phone number, and email address listed on the cover page. Additionally, the word count of the manuscript (excluding the abstract, acknowledgments, references, and figure/table captions), the word count of the English abstract, and the number of tables and figures should be provided. Finally, all authors should include their Open Researcher and Contributor ID (ORCID) (e.g., Gil-Dong Hong, http://orcid.org/0000-0003-1234-5678). Authors who do not have an ORCID should register at http://orcid.org and include the ID.

English Abstract and Keywords

The English abstract should be written in an unstructured format and not exceed 250 words. The abstract should provide a concise summary of the entire manuscript, including the main content in a manner that is easy to understand. At the bottom of the abstract, four to six keywords should be provided. It is recommended that the keywords be selected from the vocabulary listed in the Medical Subject Headings (MeSH) by the U.S. National Library of Medicine.

Main Body

The main body of the manuscript should be written in the following order: Introduction, Main Text, and Conclusion. The main text can be subdivided into several sections based on the content.

Author names and affiliations should not be included in the main body of the manuscript.

Conflicts of Interest

When submitting a manuscript, all relevant matters related to consultancy fees or any other financial or personal interests that may create a conflict of interest should be disclosed. Examples of conflicts of interest include research funding from pharmaceutical companies and political pressure from interest groups. If there are no conflicts of interest, the following statement should be included: "The authors declare no conflicts of interest."

Funding

Any funding received for the research must be clearly stated. If no funding was received, the statement "No funding" should be included.

Acknowledgments (If Applicable)

If necessary, individuals who contributed to the manuscript but did not meet the authorship criteria may be acknowledged in the Acknowledgments section. The specific roles of the contributors in the research must be clearly stated. The authors must inform and obtain consent from the individuals listed in Acknowledgments.

References

References should be written in English, and the number of references for reviews is limited to 100. The references should be listed in the order in which they are cited in the text, with Arabic numerals and double spacing. If there are six or fewer authors, all should be listed; if there are seven or more, the first three authors should be listed followed by "et al." References in Korean should be written in English as indicated in the reference itself. It is recommended that reference management software be used when preparing references.

For journal names, refer to the National Library of Medicine’s list (https://www.ncbi.nlm.nih.gov/books/NBK7256/) for English journals and the Korean Medical Journal Information (http://journals.koreamed.org) for Korean journals.

Abstracts are generally not acceptable as references; however, if unavoidable, it should be clarified that only the abstract is being cited. If citing an article that has been accepted but not yet published, it should be noted as "Online ahead of print" in square brackets.

In the main text, the reference number should be indicated in superscript following the relevant content. When citing three or more consecutive references, the range should be indicated with a hyphen between the first and last numbers. The superscript reference number should appear after the author's name when cited and after the last word of the content if there is no author. Particles should appear after the superscript, and commas and periods should precede the superscript. When there are more than three authors, "et al." is used, and the superscript follows after "et al."

A. Journal articles: Author(s), title, journal name, publication year; volume, start page–end page

- If there are six or fewer authors

Seo HK, Ji SH, Jhun HJ. Smoking prevalence and habits of physicians in Korea: a mail questionnaire survey conducted in 2000. J Korean Acad Fam Med 2007; 28: 599-603.

- If there are seven or more authors

Rose ME, Huerbin MB, Melick J, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935(1-2):40-6.

- If the author is an organization

Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension. 2002;40(5):679-86.

If published online ahead of print

Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China N Engl J Med February 28, 2020 [Online ahead of print] https://www.nejm.org/doi/full/10.1056/NEJMoa2002032. 10.1056/NEJMoa2002032.

B. Books: Author's name, Book title, Edition, Place of publication, Publisher, Year of publication (if applicable, start page–end page).

If the author is an individual

Vander Vorst A, Rosen A, Kotsuka Y. RF/Microwave Interaction with Biological Tissues. Hoboken, NJ: John Wiley & Sons, Inc.; 2005.

- If it is an edited book

Chen JZM. Canadian-Daoist Poetics, Ethics, and Aesthetics: An Interdisciplinary and Cross-cultural Study. 1st ed. 2015. Berlin, Heidelberg: Springer; 2016.

- When using a chapter from an edited book

Tan L. A Residual Energy-Based Fairness Scheduling MAC Protocol for Wireless Sensor Networks. In: Gao H, Lim L, Wang W, Li C, Chen L, editors. Web-Age Information Management: 13th International Conference, WAIM 2012, Harbin, China, August 18-20, 2012. Proceedings. Berlin, Heidelberg: Springer; 2012. p. 3546.

C. Conference Proceedings: Author's name, Title, Name of the conference proceedings (if no specific title, use the conference name), Date of the conference (year, month, day), Location of the conference, Place of publication, Publisher, Year of publication.

Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology. Proceedings of the 10th International Congress of EEMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto, Japan. Amsterdam: Elsevier; 1996.

D. Thesis or Dissertation: Author's name, Title of the thesis [dissertation], City of the awarding university, Name of the awarding university, Year, Language. (Note: The language is not included if it is English.)

Song YM. The Relationship between low serum cholesterol level and cancer mortality [dissertation]. Seoul: Seoul National Univ.; 1997. Korean.

Kaplan SJ. Post-hospital home health care: the elderly's access and utilization [dissertation]. St. Louis (MO): Washington Univ.; 1995.

E. Public Institution Documents: Name of the institution, Title, Location of the institution, Publisher, Year.

Government Accountability Office. Highlights of a Forum: Data and Analytics Innovation: Emerging Opportunities and Challenges. Washington, DC: U.S. Government Printing Office; 2016.

F. Web Page: Author, Title, Date of citation and last update, URL.

Luntz S. Almost A Third Of New FDA-Approved Pharmaceuticals Have Post-Trial Safety Events [Internet]. IFLScience. 2017 [cited 2018 Oct 30]; Available from: https://www.iflscience.com/health-and-medicine/almost-a-third-of-new-fda-approved-pharmaceuticals-have-post-trial-safety-events/

Tables (if applicable)
In principle, tables should be written in Korean. However, if it enhances the reader’s understanding or is appropriate because of the nature of the terms, it may be written in English. Tables should be concise and clear enough to explain themselves without the need to read the main text. If the table is not one that you created, permission must be obtained from the copyright holder and acknowledged in a footnote.

The title of the table should be aligned at the top left. The tables should be numbered in the order they are cited in the text. The word “Table()” should be followed by one space, the Arabic numeral, and a period. The title should not end with a period. In the main text, refer to the table as “(Table number).”

Tables should be created with double spacing and placed on separate pages. Except for the top horizontal line, no other horizontal or vertical lines should be used inside the table. If abbreviations are used in the table or if any explanation is needed, the footnotes should be provided at the bottom of the table. Use lowercase letters (a, b, c) as superscripts on the right side of the part needing an explanation and align the corresponding footnotes at the bottom.

Units used in the table should be indicated within the table itself and should not be separately noted outside the table. Avoid using unnecessary capital letters for unit symbols. When creating tables, include information such as the average, standard deviation, and sample size. In the footnotes, specify the statistical methods used. For ratios, provide both the response count and the ratio, and for correlation coefficients, provide the correlation coefficient value.

Figures and Figure Captions (if applicable)
Figures, photos, and captions should be written in Korean as a general rule. However, if it enhances the reader’s understanding, or is appropriate because of the nature of the terms, it may be written in English. If the figure is not one that you have created, you must obtain permission from the copyright holder and acknowledge this in the figure caption.

Figures or photos should be submitted as separate files in PDF, GIF, Tagged Image File Format (TIF or TIFF), or Adobe Illustrator (.ai) formats at a resolution of 600 dpi or higher. When creating figures, use bar graphs or line graphs to represent averages or proportions, and indicate the size of the standard deviation or standard error. The p-value must always be presented. Specify the statistical methods used in the figure caption. The title should end with a period.

Figures should be numbered in the order they are cited in the main text, following the word “Figure” with a single space and using Arabic numerals with a period after the number. In the main text, refer to the figure as “(Figure number).” If there are multiple images under one figure number, label them as “그림 1,” “그림 2,” and so on.

Supplementary Appendix (If Applicable)

The appendix of the manuscript must be paginated along with the table of contents and should include the list of researchers (if applicable), text (e.g., methods), figures, tables, and references. The references cited in the reference list should be included separately in the appendix. It must be submitted as a separate MS Word file and will be published unedited as additional information provided by the author.

-Supplementary Figures and Tables
Each figure should include a title and legend and must appear on the same page as the figure itself (e.g., Figure S1, Figure S2). Tables in the Supplementary Appendix should be labeled as Table S1, Table S2, and so on, and each table should include a title and footnotes (if necessary).

(2) Original article

Title page (including ORCID), English abstract (Abstract) and Keywords, Main body (Introduction, Methods, Results, Discussion), Conflicts of Interest, Funding, Acknowledgments (if applicable), References, Tables (if applicable), Figures and Figure Captions (if applicable), Appendix (if applicable) should be arranged in consecutive order.

The length of the manuscript, excluding the title page, English abstract, references, tables, figures, and figure captions, should not exceed 10,000 words (including spaces). The total number of tables and figures or photos combined should not exceed 10. The number of references should be limited to 40. The manuscript should generally follow the submission guidelines for reviews: CONSORT (http://www.consort-statement.org) for randomized controlled trials, STROBE (http://www.strobe-statement.org) for observational studies, PRISMA (http://www.prisma-statement.org) for systematic reviews and meta-analyses, and STARD (http://www.stard-statement.org) for studies on diagnostic accuracy. The main text should be written as follows:

The English abstract should be within 250 words and follow the format of Background, Methods, Results, and Conclusion. The abstract should summarize the entire paper in a concise and easy-to-understand manner. Below the abstract, 4 to 6 keywords should be listed, using terms from the MeSH as recommended by the U.S. National Library of Medicine.

 ▪ Main Body
Author information, including the author's name and affiliation, should not be included in the main body.

-Introduction: Describe the purpose of the paper and explain why it is important. Summarize the background and principles of the research and limit the references to those directly related.

-Methods: Provide a detailed and specific description of the research plan, subjects, and methods. Clearly define the research subjects and describe statistical methods in detail to allow the results in the paper to be verified and reproduced. For research involving human subjects, indicate that approval was obtained from the IRB. When mentioning equipment or reagents, include the name, manufacturing company, city, and country of the company in parentheses. If new or modified methods are used, briefly introduce them along with references. Quantify the research results and report measurement errors or uncertainties (e.g. confidence intervals) and present the p-value. Specify the statistical software used for analysis.

-Results: Present the research results clearly and logically. Use tables and figures consistent with the main body and summarize key points and trends in the text.

-Discussion: Emphasize new and important findings from the methods and results and provide conclusions based on these findings. Interpret the results in relation to other data, avoiding repetition of the results. Discuss the implications of the results, limitations in interpretation, and potential applications in future research. Compare the results with other studies, linking the conclusion to the research objectives. Propose new hypotheses based on the results and suggest appropriate ways to verify them.

(3) Case report

Title page (including ORCID), English abstract (Abstract) and Keywords, Main body (Introduction, Case Report, Discussion), Conflicts of Interest, Funding, Acknowledgments (if applicable), References, Tables (if applicable), Figures and Figure Captions (if applicable), Appendix (if applicable) should be arranged in consecutive order.

The English abstract for the case report should be written in an unstructured format and be no longer than 250 words. The abstract should summarize the entire content of the paper in a clear and easy-to-understand manner.

The manuscript length, excluding the title page, references, tables, figures, and figure captions, should not exceed 2,500 words (including spaces). The number of keywords should be between 4 and 6, and terms from the U.S. National Library of Medicine's MeSH are recommended. The number of references should be limited to 20. The total number of tables, figures, or photos combined should not exceed 10.

Author information, including the author's name and affiliation, should only be included on the title page and not in the main body.

 (4) Perspective

Title page (including ORCID), English abstract (Abstract) and Keywords, Main body, Conflicts of Interest, Funding, Acknowledgments (if applicable), References, Tables (if applicable), Figures and Figure Captions (if applicable), Appendix (if applicable) should be arranged in consecutive order.

The English abstract and manuscript for the case report should be written in an unstructured format. The abstract should be no longer than 250 words and must summarize the entire content of the paper in a clear and easy-to-understand manner.

The manuscript length, excluding the title page, references, tables, figures, and figure captions, should not exceed 1,500 words (including spaces). The number of keywords should be between 4 and 6, and terms from the U.S. National Library of Medicine's MeSH are recommended. The number of references should be limited to 20. The total number of tables, figures, or photos combined should not exceed 3.

Author information, including the author's name and affiliation, should only be included on the title page and not in the main body.

 (5) Editorial

Title page (including ORCID), Main body, Conflicts of Interest, References, Tables (if applicable), Figures and Figure Captions (if applicable), Appendix (if applicable) should be arranged in consecutive order.

The manuscript should be written in an unstructured format and should not exceed 750 words (including spaces) excluding the title page, references, tables, figures, and figure captions. The number of references was limited to 10. The total number of tables, figures, or photos combined should not exceed 1.

Author information, including the author's name and affiliation, should only be included on the title page and not in the main body.

(6) Correspondence

Title page (including ORCID), Main body, Conflicts of Interest, Funding, Acknowledgments (if applicable), References, Tables (if applicable), Figures and Figure Captions (if applicable), Appendix (if applicable) should be arranged in consecutive order.

The manuscript should be written in an unstructured format, and the length must not exceed 400 words (including spaces), excluding the title page, references, tables, figures, and figure captions. The number of references should be limited to 10. The total number of tables, figures, or photos combined should not exceed 1.

Author information, including the author's name and affiliation, should only be included on the title page and not in the main body. 

3. Submission of Manuscripts

All manuscript submissions must be made through the online submission system of the Society for Korean Obesity and Metabolism Studies (ACOMS+ Obesity and Metabolism Journal) available at accesson.kr. All subsequent review and editorial processes will also be conducted through this system. The progress of the manuscript review, along with related inquiries and responses, can be checked at any time through the online submission system. Prior to submitting a manuscript, authors must review the "Author’s Guide" available in the online submission system.

4. Manuscript Review and Acceptance

All submitted manuscripts will be reviewed by at least two experts in the relevant field, and the decision on manuscript acceptance will be based on the results of the review. If the review results differ, the manuscript will be subject to re-evaluation by the Editorial Board before the final acceptance decision is made. If the Editorial Board requests revisions to the manuscript based on the expert review, the author must make the revisions within 4 weeks in accordance with the review comments and submit the revised manuscript along with a detailed list of the revisions as a 'Response to the Author' through the online submission system. If the author does not submit the revised manuscript within 12 weeks after receiving revision recommendations, the manuscript will be considered abandoned for publication. The final decision regarding the acceptance of the manuscript will be made by the Editorial Board after the expert review process. Additionally, the Editorial Board may recommend revisions or withhold publication for manuscripts that do not comply with the guidelines.

5. Publication Decision

Once the decision to publish the manuscript has been made, the author will receive a PDF version of the manuscript file. The author must review the file within 2 days to check for any errors, such as typos or other issues, and request corrections if necessary. If a significant error that violates the submission guidelines is discovered after the publication decision, the Editorial Board will request revisions from the author. Publication may be delayed until the necessary corrections are completed.

1) Manuscript Revision
In accordance with the editorial policy, the manuscript may be revised in some parts, as long as such revisions do not affect its main content or message.

2) Transfer of Copyright
When submitting a new manuscript, all authors must sign online to consent to the transfer of copyright. The submitting author is considered the signer. Upon signing, the copyright of the manuscript is transferred to the Obesity Metabolism Research Society, which will hold the rights to publish, distribute, and print the accepted manuscript in academic journals or other media.

6. OA Policy
The Obesity Metabolism Research Journal follows a CC BY-NC (Attribution-NonCommercial) license regarding the reuse of academic papers. This allows for the work to be used non-commercially, provided the author and source are credited, and permits the creation of derivative works based on the original material.
Authors can post the post-print version of their articles on their personal websites or the journal's website under the CC BY-NC license immediately after publication.

 

<Supplementary Provisions>
(Effective Date) These regulations are effective from February 18, 2022.

<Supplementary Provisions>
(Effective Date) These regulations are effective from October 6, 2023.

<Supplementary Provisions>
(Effective Date) These regulations are effective from May 3, 2024.

<Supplementary Provisions>
(Effective Date) These regulations are effective from December 20, 2024.

<Supplementary Provisions>
(Effective Date) These regulations are effective from April 20, 2025.

 

Attachments
aom_(1).ens
투고가이드_개정_20250420.docx

Archives of Obesity and Metabolism